AstraZeneca PLC (NYSE:AZN) is lagging the broader market this year so far, with shares declining by over 8%. The ...

Oct 21 (Reuters) - AstraZeneca said on Wednesday the US Food and Drug Administration granted accelerated approval for its ...

Oct 20 () - AstraZeneca said on Tuesday that it is working with Oracle to ‌use AI and real-world data to identify ‌eligible patients for clinical trials and monitor safety signals, among ​other ...

Oct 20 () - Amgen and AstraZeneca said on Tuesday their asthma drug helped reduce swallowing difficulties and achieved ...

Jefferies, the investment bank, estimates a 59% probability that AstraZeneca PLC (LSE:AZN, NYSE:AZN)’s zibotentan succeeds in ...

The initiative aims to address recruitment hurdles by enabling healthcare providers to spot suitable individuals with ease.

Several Oncology Catalysts, One Earnings Question AstraZeneca PLC (NYSE:AZN) enters the3-27 European Society for Medical ...

AstraZeneca will tap AI-focused insitro to find new targets for metabolic dysfunction-associated steatohepatitis and ...

AstraZeneca is teaming up with Oracle to refine clinical research, in the latest artificial-intelligence partnership in the ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion ...

AstraZeneca and Oracle team up on AI, aiming to speed up clinical trials and improve patient care pathways, with the first ...

AstraZeneca and Oracle will use AI and real-world health data to find trial patients sooner, starting with a hypertension ...